Ha Tay Pharmaceutical JSC reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported revenue was VND 491,595.08 million compared to VND 325,099.39 million a year ago. Net income was VND 22,841.99 million compared to VND 8,673.72 million a year ago.
For the nine months, revenue was VND 1,303,082.14 million compared to VND 1,163,060.84 million a year ago. Net income was VND 60,225.6 million compared to VND 49,032.39 million a year ago.